¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reverse passive anaphylaxis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® anaphylaxis ÇÑ±Û ¾Æ³ªÇʶô½Ã½º, °ú¹ÎÁõ
¼³¸í   
  ¾Æ³ªÇʶô½Ã½º¶ó´Â ¸»Àº Á¦ 1Çü °ú¹Î¹ÝÀÀ°ú °°Àº ¸»·Î ¿Ü°èÀÇ ¹°Áú¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀÀÌ Áö³ªÄ¡°Ô Ç×ÁøµÇ¾î Àִ º´ÀûÀΠ»óŸ¦ ¸»ÇÑ´Ù. ¸é¿ªÀ̶õ ¿ÜºÎ¹°Áú¿¡ ´ëÇÑ ¹æ¾î¸¦ ¸ñÀûÀ¸·Î Çϴ ¼¼Æ÷µéÀǠȰµ¿À» ÀǹÌÇϸç, ¿©±â¿¡´Â Ç×üÀÇ Çü¼º, ¼¼Æ÷µéÀÇ Æ÷½ÄÀÛ¿ë(¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°ÁúÀ» ¸é¿ª±â´ÉÀ» Çϴ ¼¼Æ÷°¡ Àâ¾Æ¸Ô´Â °Í)µîÀÌ Æ÷ÇԵȴÙ. Ç×üÀÇ Çü¼ºÀº ¿ÜºÎ·ÎºÎÅÍ µé¾î¿Â ¹°ÁúÀ» ¿ì¼± Å«Æ÷½Ä¼¼Æ÷ µîÀÌ Æ÷½ÄÀ» Çϰí À̰Ϳ¡ ´ëÇÑ Á¤º¸¸¦ T-¸²ÇÁ±¸¿¡°Ô Àü´ÞÇϰí T-¸²ÇÁ±¸´Â ÀÌ Á¤º¸¸¦ Ã³¸®ÇÏ¿© Áý¾àµÈ Á¤º¸¸¦ B-¸²ÇÁ±¸¿¡°Ô Àü´ÞÇϸç ÀÌ ¼¼Æ÷·Î ÇÏ¿©±Ý ±× ¹°Áú ¿¡ ´ëÇÑ Ç×ü¸¦ »ý¼ºÇϰԠÇÑ´Ù. Ç×ü´Â ¿ÜºÎÀÇ ¹°Áú°ú Á¤È®È÷ °áÇÕÇÏ¿© ¿ÜºÎÀÇ ¹°ÁúÀǠȰ¼ºÈ­¸¦ ¾ø¾Ö´Â ¹°ÁúÀÌ´Ù. ÀÌ·¸°Ô Çü¼ºµÈ Ç×üÁß¿¡¼­ IgE¿¡ ºÎÂøµÉ ¼ö ÀÖ´Â, Áï À̹̠Ç×ü IgE°¡ Çü¼ºµÈ(ÀÌ·¸°Ô µÇ±â À§Çؼ­´Â ±× ¹°ÁúÀÌ ÀÌÀü¿¡ ÇÑ ¹ø ¸ö¼Ó¿¡ µé¾î ¿Ô¾î¾ß ÇÑ´Ù) ¹°ÁúÀÌ È÷½ºÅ¸¹Î µîÀÇ ¿©·¯ ¹°ÁúÀÌ ³ª¿À°Ô µÇ°í ÀÌ·± ¹°Áúµé¿¡ ÀÇÇØ¼­ »ý±â´Â ¿©·¯ °¡Áö ½Åü¿¡ ÇطοÝÀÀÀÌ »ý°Ü³­´Ù. ±×·¡¼­ ÇÊ¿ä ÀÌ»óÀ¸·Î °ú¹ÎÇÑ ÀÌ·¯ÇÑ ÇüÅÂÀÇ ¸é¿ªÀÛ¿ëÀ» °ÅÄ¡´Â ¹ÝÀÀÀ» ¾Æ´ÏÇʶô½Ã½º¶ó ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reverse passive anaphylaxis
    ¿ª¼öµ¿¾Æ³ªÇʶô½Ã½º
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • passive cutaneous anaphylaxis
    ¼öµ¿ÇǺξƳªÇʶô½Ã½º
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º
  • exercise-induced anaphylaxis
    ¿îµ¿À¯¹ß¾Æ³ªÇʶô½Ã½º
  • generalized anaphylaxis
    Àü½Å¾Æ³ªÇʶô½Ã½º
  • local anaphylaxis
    ±¹¼Ò¾Æ³ªÇʶô½Ã½º
  • reverse action clasp
    ¿ªÀÛ¿ë°¥°í¸®
  • reverse mutation
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • reverse osmosis
    ¿ª»ïÅõ
  • reverse primer
    µÞ±æÀâÀÌ
  • reverse transcriptase
    ¿ªÀü»çÈ¿¼Ò
  • reverse transcriptase polymerase chain reaction
    ¿ªÀü»çÈ¿¼ÒÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • reverse transcription
    ¿ªÀü»ç
  • reverse Waters position
    ¿ª¿öÅͽºÀÚ¼¼
  • passive
    ¼öµ¿-, Çǵ¿-
  • passive aggressive personality
    ¼öµ¿°ø°ÝÀΰÝ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º
  • passive
    ¼öµ¿-, Çǵ¿-
  • passive smoking
    °£Á¢Èí¿¬
  • reverse mutation
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • reverse osmosis
    ¿ª»ïÅõ
  • reverse transcriptase
    ¿ªÀü»çÈ¿¼Ò, ¿ªÀü»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reverse passive anaphylaxis
    ¿ª¼öµ¿¾Æ³ªÇʶô½Ã½º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • passive cutaneous anaphylaxis
    ¼öµ¿ÇǺξƳªÇʶô½Ã½º
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º
  • exercise-induced anaphylaxis
    ¿îµ¿À¯µµ¾Æ³ªÇʶô½Ã½º
  • generalized anaphylaxis
    Àü½Å¾Æ³ªÇʶô½Ã½º
  • local anaphylaxis
    ±¹¼Ò¾Æ³ªÇʶô½Ã½º
  • reverse action clasp
    ¿ªÀÛ¿ë°¥°í¸®
  • reverse mutation
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • reverse osmosis
    ¿ª»ïÅõ
  • reverse primer
    µÞ±æÀâÀÌ
  • reverse Waters position
    ¿ª¿öÅͽºÀÚ¼¼
  • reverse transcriptase
    ¿ªÀü»çÈ¿¼Ò
  • reverse transcription
    ¿ªÀü»ç
  • passive congestion
    ¼öµ¿¿ïÇ÷
  • passive diffusion
    ¼öµ¿È®»ê
  • passive edema
    ¼öµ¿ºÎÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • agglutination, reverse
    ¿ªÀÀÁý¹ý
  • agglutination, passive
    ¼öµ¿ÀÀÁý
  • appreciation of passive movement
    ¼öµ¿¿îµ¿°¨°¢.
  • hemagglutination, passive
    ¼öµ¿ Ç÷±¸ÀÀÁý
  • hemagglutination, reversed passive
    ¿ª¼öµ¿ Ç÷±¸ÀÀÁý¹ÝÀÀ
  • immunity, passive
    ¼öµ¿¸é¿ª
  • immunization, passive
    ¼öµ¿¸é¿ª
  • indirect passive agglutination
    °£Á¢¼öµ¿ÀÀÁý(¹ÝÀÀ).
  • personality disorder, passive
    ¼öµ¿¼º(áôÔÑàõ) ÀΰÝÀå¾Ö
  • personality disorder, passive-aggressive
    ¼öµ¿°ø°Ý¼º ÀΰÝÀå¾Ö
  • personality, passive aggresive
    ¼öµ¿°ø°Ý¼º ÀΰÝ.
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã.
  • anaphylaxis
    ¾Æ´ÏÇʶô½Ã
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º
  • anaphylaxis
    °ú¹ÎÁõ, ¾Æ³ªÇʶô½Ã½º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reverse passive anaphylaxis
    ¿ª¼öµ¿(æ½áôÔÑ)¾Æ³ªÇʶô½Ã½º.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reverse anaphylaxis
    ¿ª¾Æ³ªÇʶô½Ã(潡­)
  • reverse passive hemagglutination=RPHA
    ¿ª¼öµ¿Ç÷±¸ÀÀÁý¹ý
  • passive anaphylaxis
    Çǵ¿Àû(ù¬ÔÑîÜ)¾Æ³ªÇʶô½Ã.
  • passive anaphylaxis
    Çǵ¿Àû(ù¬ÔÑîÜ)¾Æ³ªÇʶô½Ã½º.
  • passive cutaneous anaphylaxis
    Çǵ¿Àû ÇǺÎ(ù¬ÔÑîÜù«Ý±)¾Æ³ªÇʶô½Ã½º.
  • passive cutaneous anaphylaxis
    Çǵ¿Àû ÇǺÎ(ù¬ÔÑîÜù«Ý±)¾Æ³ªÇʶô½Ã.
  • passive cutaneous anaphylaxis
    ¼öµ¿ÇǺξƳªÇʶô½Ã½º
  • passive cutaneous anaphylaxis
    Çǵ¿Àû ÇǺÎ(ù¬ÔÑîÜù«Ý±)¾Æ³ªÇʶô½Ã½º.
  • passive systemic anaphylaxis
    ¼öµ¿Àü½Å¾Æ³ªÇʶô½Ã½º
  • agglutination, reverse
    ¿ªÀÀÁý¹ý
  • endocytosis, reverse
    ¼¼Æ÷³» ÀÌÀÔ(Çö»ó), ¿ª
  • reverse Colles fracture
    ¿ª(æ½) Äݸ®½º °ñÀý(¡­Íéï¹).
  • reverse action clasp
    ¿ªÀÛ¿ë°¥°í¸®.
  • reverse comma sign
    ¿ªÄÞ¸¶Â¡ÈÄ, ¿ª½°Ç¥Â¡ÈÄ(¡­ó£ý¦).
  • reverse comma sign
    ¿ªÄÞ¸¶Â¡ÈÄ(潡­ó£ý¦), ¿ª½°Ç¥Â¡ÈÄ(潡­øúó£ý¦)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • passive anaphylaxis
    ¼öµ¿(áôÔÑ) ¾Æ³ªÇʶô½Ã½º
  • active anaphylaxis
    Ȱ¼º(üÀàõ)¾Æ³ªÇʶô½Ã½º
  • aggregate anaphylaxis
    ÀÀÁý(ëêó¢)¾Æ³ªÇʶô½Ã½º
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã½º
  • cytotoxic anaphylaxis
    ¼¼Æ÷µ¶¼º(á¬øàÔ¸àõ) ¾Æ³ªÇʶô½Ã½º
  • cytotropic anaphylaxis
    Çâ¼¼Æ÷(ù÷á¬øà) ¾Æ³ªÇʶô½Ã½º
  • reverse bend
    ¿ª(æ½)±ÁÀÌ
  • reverse burst titration
    ¿ª°æ ÀûÁ¤(æ½ÌËîÙïÒ)
  • reverse dialysis
    ¿ªÅõ¼®(æ½÷âà°)
  • reverse transcriptase
    ¸®¹ö½º Æ®¶õ½ºÅ©¸³Å×À̽º
  • reverse transcription
    ¿ªÀü»ç(æ½ï®ÞÐ)
  • reverse turn
    ¿ª(æ½)µ¹ÀÌ
  • passive agglutination
    ¼öµ¿ ÀÀÁý(áôÔÑëêó¢)
  • passive diffusion
    ¼öµ¿ È®»ê(áôÔÑüªß¤)
  • passive hemagglutination
    ¼öµ¿ Ç÷¾×ÀÀÁý(áôÔÑúìäûëêó¢)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylaxis
    ¾Æ³ªÇʶô½Ã, °ú¹ÎÁõ
  • reverse
    ¿ªÀü, ¹ÝÀü
  • reverse piezoelectric effect
    ¿ª¾ÐÀüÈ¿°ú
  • passive
    Çǵ¿ÀÇ, ¼öµ¿ÀÇ, ¼Ò±ØÀûÀÎ
  • passive movement
    ¼öµ¿¿îµ¿, Çǵ¿¿îµ¿
  • passive shimming
    ¼öµ¿º¸Á¤
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RPA radial photon apsorptiometry; replication protein A; resultant physiologic acceleration; reverse pas...
PCA para-chloramphetamine; parietal cell antibody; passive cutaneous anaphylaxis; patient care assistant...
RT radiologic technologist; radiotelemetry; radiotherapy; radium therapy; rapid tranquilization; reacti...
SRS-A Slow Reacting Substance of Anaphylaxis
ASA acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PCA Passive Cutaneous Anaphylaxis
RCA reverse cutaneous anaphylaxis
RPAR reverse passive Arthus reaction
RPH reverse passive haemagglutination
ACA Active cutaneous anaphylaxis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • heterologous anaphylaxis
    ÀÌÁ¾ ¾Æ³ªÇʶô½Ã
  • reverse action
    ¹Ý´ë ÀÛ¿ë
  • reverse agglutination
    ¿ªÀÀÁý¹ý
  • reverse articulation teeth
    ¿ª±³ÇÕ Ä¡¾Æ
    »ó¾Ç ±¸Ä¡ÀÇ ÇùÃø ±³µÎ¸¦ ÇÏ¾Ç Ä¡¾ÆÀÇ Á᫐ ¿Í¿¡ À§Ä¡½Ãų ¼ö ÀÖµµ·Ï °í¾ÈµÈ ±¸Ä¡.
  • reverse bend
    ¿ª¸¸°î
  • reverse mutation
    ȯ¿ø µ¹¿¬ º¯ÀÌ
  • reverse occlusion
    ¹Ý´ë ±³ÇÕ
  • reverse piezoelectric effect
    ¿ª¾ÐÀü È¿°ú
  • reverse smoking
    ¹Ý´ë Èí¿¬
  • reverse transcription
    ¿ªÀü»ç
  • continuous passive motion
    Áö¼ÓÀûÀÎ ¼öµ¿ ¿îµ¿, °è¼ÓÀûÀÎ ¼öµ¿ ¿îµ¿, Áö¼ÓÀûÀÎ ¼öµ¿Àû ¿îµ¿
    Á¤ÇØÁø ¿îµ¿ ¹üÀ§³»·Î °üÀýÀ» ¿òÁ÷ÀÌ´Â ±â°è³ª ´Ù¸¥ »ç¶÷¿¡ ÀÇÇØ ÀÌ·ç¾îÁö´Â ½ÅüÀÇ ÁÖ±âÀûÀÎ ¿îµ¿.
  • passive agglutination
    ¼öµ¿ ÀÀÁý
  • passive dependent
    Çǵ¿ ÀÇÁ¸¼º. ¼öµ¿ ÀÇÁ¸¼ºÀÇ
  • passive edema
    ¼öµ¿ ºÎÁ¾
  • passive exercise
    ¼öµ¿Àû ¿îµ¿
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
passive anaphylaxis A reaction resulting from inoculation of antigen in an animal previously inoculated intravenously with specific antiserum from another animal, a latent period being required between the two inoculations.
Synonym: antiserum anaphylaxis.
(05 Mar 2000)
passive cutaneous anaphylaxis An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. Pca is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity.
(12 Dec 1998)
passive cutaneous anaphylaxis test An animal is injected intradermally with antibody (usually IgE) and subsequently challenged intravenously with a mixture of antigen and Evans blue dye 24-48 hours later. A dark blue area indicates a positive reaction due to the leakage of the dye at the site of antigen-antibody reactions.
(05 Mar 2000)
reversed passive anaphylaxis An anaphylactic reaction induced in an animal injected with a specific antigen, which will bind to reactive tissue, and then, after a latent period, with serum from another animal previously sensitised to the identical antigen.
Synonym: reversed anaphylaxis.
(05 Mar 2000)
reverse passive haemagglutination If antibodies are bonded to the surface of red blood cells haemagglutination will occur if the appropriate bi or multivalent antigen is added in soluble or microparticulate form. Used as a test for for example Hepatitis B virus in the serum.
(18 Nov 1997)
active anaphylaxis Reaction following inoculation of antigen in a subject previously sensitised to the specific antigen, in contrast to passive anaphylaxis.
(05 Mar 2000)
aggregate anaphylaxis <pharmacology> As opposed to prophylaxis. A system or treatment that leads to damaging effects on the organism.
<immunology> Now reserved for those inflammatory reactions resulting from combination of a soluble antigen with IgE bound to a mast cell that leads to degranulation of the mast cell and release of histamine and histamine like substances, causing localised or global immune reponses.
Results in an acute allergic reaction with shortness of breath, rash, wheezing, hypotension.
See: hypersensitivity.
(18 Nov 1997)
anaphylaxis <pharmacology> As opposed to prophylaxis. A system or treatment that leads to damaging effects on the organism.
<immunology> Now reserved for those inflammatory reactions resulting from combination of a soluble antigen with IgE bound to a mast cell that leads to degranulation of the mast cell and release of histamine and histamine like substances, causing localised or global immune reponses.
Results in an acute allergic reaction with shortness of breath, rash, wheezing, hypotension.
See: hypersensitivity.
(18 Nov 1997)
antiserum anaphylaxis A reaction resulting from inoculation of antigen in an animal previously inoculated intravenously with specific antiserum from another animal, a latent period being required between the two inoculations.
Synonym: antiserum anaphylaxis.
(05 Mar 2000)
generalised anaphylaxis The immediate response, involving smooth muscles and capillaries throughout the body of a sensitised individual, that follows intravenous (and occasionally intracutaneous) injection of antigen (allergen).
See: anaphylactic shock.
Synonym: systemic anaphylaxis.
(05 Mar 2000)
reversed anaphylaxis An anaphylactic reaction induced in an animal injected with a specific antigen, which will bind to reactive tissue, and then, after a latent period, with serum from another animal previously sensitised to the identical antigen.
Synonym: reversed anaphylaxis.
(05 Mar 2000)
pharmacologic mediators of anaphylaxis Substances released from mast (and other) cells by the reaction of antigen and specific homocytotropic antibody on their surfaces; they include histamine, slow-reacting substance of anaphylaxis (SRS-A), bradykinin, and (in some species of animals) serotonin.
(05 Mar 2000)
chronic anaphylaxis A haemorrhagic and necrotizing inflammation developing in the ileum (and also the colon) of sensitised dogs when they are fed a second dose of the sensitizing material.
Synonym: chronic anaphylaxis.
(05 Mar 2000)
slow-reacting factor of anaphylaxis Slow-reacting substance of anaphylaxis (SRS-A), a leukotriene of low molecular weight which is released in anaphylactic shock and produces slower and more prolonged contraction of muscle than does histamine; it is active in the presence of antihistamines (but not epinephrine) and seems not to occur preformed in mast cells, but as a result of an antigen-antibody reaction on the granules.
Compare: peptidyl leukotrienes.
Synonym: slow-reacting factor of anaphylaxis.
(05 Mar 2000)
slow reacting substance of anaphylaxis <immunology> Potent bronchoconstrictor and inflammatory agent released by mast cells, an important mediator of allergic bronchial asthma.
A mixture of three leukotrienes (LTC4 mainly, LTD4 and LTE4)
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaphylaxis
    °ú¹ÎÁõ(°ú´Ô¼º)ÀÇ;¾Æ³ªÇʶô½Ã½ºÀÇ
  • passive
    ¼öµ¿¼ºÀÇ; ¼ø¼øÈ÷ µû¸£´Â
  • passive
    ¼öµ¿ÀÇ;¹«ÀúÇ×ÀÇ;Ȱ¹ßÇÏÁö ¸øÇÑ
  • passive belt
    ÀÚµ¿ ¾ÈÀü ¹ëÆ®
  • passive euthanasia
    ¼Ò±ØÀû ¾È¶ô»ç
  • passive immunity
    ¼öµ¿ ¸é¿ª
  • passive immunization
    ¼öµ¿ ¸é¿ª
  • passive obedience
    Àý´ë º¹Á¾;¹¬Á¾
  • passive resistance
    ¼Ò±ØÀû ÀúÇ×
  • passive resister
    ¼Ò±ØÀû ÀúÇ×ÀÚ
  • passive restraint
    ¼öµ¿Àû ¾ÈÀüÀåÄ¡
  • passive sattelite
    ¼öµ¿ À§¼º
  • passive smoking
    °£Á¢ Èí¿¬
  • passive voice
    ¼öµ¿ÅÂ
  • reverse
    ¿ªÀü½ÃŰ´Ù; ¹Ý´ë; µÞ¸é; ÆÐ¹è
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á